Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.mehy.2021.110557 http://scihub22266oqcxt.onion/10.1016/j.mehy.2021.110557 33730601!7935670!33730601     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Med+Hypotheses 2021 ; 150 (ä): 110557 Nephropedia Template TP {{tp|p=33730601|t=2021. Etoricoxib may inhibit cytokine storm to treat COVID-19 |pdf=|usr=}}{{33730601}} gab.com Text Etoricoxib may inhibit cytokine storm to treat COVID-19 JO: Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=33730601 #FOAvip The worldwide spread of COVID-19 has caused an unprecedented disaster. The emergence of COVID-19-mediated cytokine storm is one of the most important contributors to the development of acute and severe illness in patients. At present, there is an urgent need for drugs that can inhibit cytokine storm to treat COVID-19. In the absence of specific drugs and vaccines, it is important to screen existing drugs as potential treatments. This article introduces a potential repositioning of the existing drug etoricoxib, which may inhibit cytokine storm to treat COVID-19 through reducing the activity of Cyclooxygenase-2 in the conversion of arachidonic acid to prostaglandin. Twit Text FOAVip Etoricoxib may inhibit cytokine storm to treat COVID-19 ????Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=33730601 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33730601 #FOAvip English Wikipedia <ref>{{Cite pmid|33730601}}</ref> Etoricoxib may inhibit cytokine storm to treat COVID-19 #MMPMID33730601 Wang R Med Hypotheses 2021[May]; 150 (ä): 110557 PMID33730601show ga The worldwide spread of COVID-19 has caused an unprecedented disaster. The emergence of COVID-19-mediated cytokine storm is one of the most important contributors to the development of acute and severe illness in patients. At present, there is an urgent need for drugs that can inhibit cytokine storm to treat COVID-19. In the absence of specific drugs and vaccines, it is important to screen existing drugs as potential treatments. This article introduces a potential repositioning of the existing drug etoricoxib, which may inhibit cytokine storm to treat COVID-19 through reducing the activity of Cyclooxygenase-2 in the conversion of arachidonic acid to prostaglandin. |*COVID-19 Drug Treatment[MESH] |Cytokine Release Syndrome/*drug therapy[MESH] |Drug Repositioning[MESH] |Etoricoxib/*therapeutic use[MESH]Etoricoxib may inhibit cytokine storm to treat COVID-19 (epmc).pdf DeepDyve Pubget Overpricing